Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 18, Issue 3-4, 2013, Pages 333-343

  Cleary, Margot P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Animal models; Aromatase; Breast cancer; High fat diets; Leptin; Mammary tumors; Mice; Obesity; Obesity prone; Overweight; Rats

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; EVEROLIMUS; FAT; GROWTH FACTOR; INSULIN; LEPTIN; LEPTIN RECEPTOR; METHYLNITROSOUREA; PROGESTERONE RECEPTOR; SOMATOMEDIN C;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; BREAST CANCER; BREAST DEVELOPMENT; BREAST TUMOR; CALORIE; CANCER INCIDENCE; CANCER PROGNOSIS; CARCINOGENESIS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; IN VITRO STUDY; LATENT PERIOD; LOW FAT DIET; NEOPLASM; NONHUMAN; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTOR; SEXUAL MATURITY; TUMOR GROWTH; TUMOR VOLUME; WEIGHT CHANGE;

ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; MICE; OBESITY;

EID: 84890016588     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-013-9300-x     Document Type: Article

References (79)

1. Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, et al. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 2010;29:641-53.
2. Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med. 1997;216:28-43.
3. Rose DP, Vona-Davis L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas. 2010;66:33-8.
4. Pierobon M, Frankenfeld CL. Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137:307-14.
5. Suzuki S, Kojima M, Tokudome S, Mori M, Sakauchi F, Wakai K, et al. Obesity/weight gain and breast cancer risk: findings from the Japan Collaborative Cohort Study for the Evaluation of Cancer Risk. J Epidemiol. 2013;23:139-45.
6. Stark A, Stahl MS, Kirchner HL, Krum S, Prichard J, Evans J. Body mass index at the time of diagnosis and the risk of advanced stages and poorly differentiated cancers of the breast: findings from a case-series study. Int J Obesity. 2010;34:1381-6.
7. Panagoupoulou P, Gogas H, Dessypris N, Maniadakdis N, Fountzilas G, Petridou ET. Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study. Eur J Epidemiol. 2012;27:857-66.
8. Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, et al. Obesity at diagnosis is associated with inferior outcomes in hormone-receptor-positive operable breast cancer. Cancer. 2012;118:5937-46.
9. Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Annals N Y Acad Sci. 2011;1229:45-52.
10. Lysaght J, van der Stok EP, Allott EH, Casey R, Donohoe CL, Howard JM, et al. Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue. Cancer Lett. 2011;312:62-72.
11. Wang Y-Y, Lehuéde C, Laurent V, Dirat B, Dauvillier S, Bochet L, et al. Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer. Cancer Lett. 2012;324:142-51.
12. Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008;114:71-83.
13. Wolff GL, Roberts DW, Mountjoy KG. Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome. Physiol Genomics. 1999;1:151-63.
14. y gene on mammary-gland tumors, hepatomas, and normal growth in mice. J Natl Cancer Inst. 1961;26:969-83.
15. vy- a high hepatoma and mammary tumor strain of mice. J Natl Cancer Inst. 1968;40:1161-6.
16. Wolff GL, Medina D, Umholtz RL. Manifestation of hyperplastic alveolar modules and mammary tumors in "viable yellow" and non-yellow mice. J Natl Cancer Inst. 1979;63:781-5.
17. vy) F1 hybrid mice. J Tox Environ Health. 1982;10:131-42.
18. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Heredity. 1950;41:317-8.
19. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32.
20. Heston WE, Vlahakis G. Genetic obesity and neoplasia. J Natl Cancer Inst. 1962;29:197-209.
21. Halter SA, Dempsey PJ, Matsui Y, Stokes K, Graves-Deal R, Hogan BLM, et al. Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-α. Characterization of mammary gland and skin proliferations. Am J Pathol. 1992;140:1131-46.
22. Cleary MP, Phillips FC, Getzin SC, Jacobson TL, Jacobson MK, Christensen TA, et al. Genetically obese MMTV-TGF-α/LepobLepob mice do not develop of mammary tumors. Breast Cancer Res Treat. 2003;77:205-15.
23. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med. 1995;1:1311-4.
24. db female mice do not develop oncogene-induced mammary tumors. Exp Biol Med. 2004;229:182-93.
25. Hu X, Juneja SC, Maihle NJ, Cleary MP. Leptin- a growth factor for normal and malignant breast cells and normal mammary gland development. J Natl Cancer Inst. 2002;94:1704-11.
26. Dieudonne M-N, Machinal-Quelin F, Serazin-Leroy V, Leneveu M-C, Pecquery R, Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Comm. 2002;293:622-8.
27. Laud K, Gourdou I, Pessemesse L, Peyrat JP, Dijane J. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol. 2002;188:219-26.
28. Klurfeld DM, Lloyd LM, Welch CB, Davis MJ, Tulp OL, Kritchevsky D. Reduction of enhanced mammary carcinogenesis in LA/N-cp (corpulent) rats by energy restriction. Proc Soc Exp Biol Med. 1991;196:381-4.
29. Hakkak R, Holley AW, MacLeod SL, Simpson PM, Fuchs GJ, Jo CH, et al. Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats. Breast Cancer Res. 2005;7:R627-33.
30. Hakkak R, MacLeod S, Shaaf S, Holley AW, Simpson P, Fuchs G, et al. Obesity increases the incidence of 7,12-dimthylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model. Int J Oncol. 2007;30:557-63.
31. de Assis S, Wang M, Goel S, Foxworth A, Helferich WG, Hilakivi-Clarke L. Excessive weight gain during pregnancy increases carcinogen-induced mammary tumorigenesis in Sprague-Dawley and lean and obese Zucker rats. J Nutr. 2006;136:998-1004.
32. Lee WM, Lu S, Medline A, Archer MC. Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N-methyl-N-nitrosurea. Cancer Lett. 2001;162:155-60.
33. Freedman LS, Clifford C, Messina M. Analysis of dietary fat, calories, body weight, and the development of mammary tumors in rats and mice: a review. Cancer Res. 1990;50:5710-9.
34. Albanes D. Total calories, body weight, and tumor incidence in mice. Cancer Res. 1987;47:1987-92.
35. Welsch CW. Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res. 1992;52:2040s-8s.
36. Welsch CW. Interrelationship between dietary lipids and calories and experimental mammary gland tumorigenesis. Cancer. 1994;74:1055-62.
37. Pariza MW. Fat, calories, and mammary carcinogenesis: net energy effects. Am J Clin Nutr. 1987;45:261-3.
38. Cleary MP, Grande JP, Maihle NJ. Effect of a high fat diet on body weight and mammary tumor latency in MMTV-TGF-α mice. Int J Obesity. 2004;28:956-62.
39. Cleary MP, Grande JP, Juneja SC, Maihle NJ. Effect of dietary-induced obesity and mammary tumor development in MMTV-neu female mice. Nutr Cancer. 2004;50:174-80.
40. Dogan S, Hu X, Zhang Y, Maihle NJ, Grande JP, Cleary MP. Effects of high fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-α mice. Breast Cancer Res. 2007;9:R91.
41. Khalid S, Hwang D, Babichev Y, Kolli R, Altamentova S, Koren S, et al. Evidence for tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis. Breast Cancer Res Treat. 2010;122:647-65.
42. MacLean PS, Giles ED, Johnson GC, McDaniel SM, Fleming-Elder BK, Gilman KA, et al. A surprising link between the energetics of ovariectomy-induced weight gain and mammary tumor progression in obese rats. Obesity. 2010;18:696-703.
43. Giles ED, Wellberg EA, Astling DP, Anderson SM, Thor AD, Jindal S, et al. Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer. Cancer Res. 2012;72:6490-501.
44. Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol. 1997;273:R725-30.
45. Madsen AN, Hansen G, Paulsen SJ, Lykkegaard K, Madsen AN, Hansen G, et al. Long-term characterization of diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. JEndocrinol. 2010;206:287-96.
46. Ricci MR, Levin BE. Ontology of diet-induced obesity in selectively bred Sprague-Dawley rats. Am J Physiol. 2003;285:R610-8.
47. Paulsen SJ, Jelsing J, Madsen AN, Hansen G, Lykkegaard K, Larsen LK, et al. Characterization of β-cell mass and insulin resistance in diet-induced obese and diet-resistant rats. Obesity. 2010;18:266-73.
48. Thompson HJ, McGinley JN, Rothhammer K, Singh M. Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis. 1995;16:2407-11.
49. Lu J, Jiang C, Mitrenga T, Cutter G, Thompson HJ. Pathogenetic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the rat. Carcinogenesis. 1998;19:223-7.
50. Singh M, McGinley JN, Thompson HJ. A comparison of the histopathology of premalignant and malignant mammary gland lesions induced in sexually immature rats with those occurring the human. Lab Invest. 2000;80:221-31.
51. Matthews SB, Zhu Z, Jiang W, McGinley J, Thompson HJ. Excess weight gain accelerates carcinogenesis in pemenopausal breast cancer model. Cancer Prev Res. 2013; (in press).
52. Lautenbach A, Budde A, Wrann CD, Teichmann B, Vieten G, Karl T, et al. Obesity and the associated mediators leptin, estrogen and IGF-I enhance proliferation and early tumorigenesis of breast cancer cells. Nutr Cancer. 2009;61:484-91.
53. Bergen HT, Mizuno TM, Taylor J, Mobbs CV. Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and propiomelanocortin. Endocrinology. 1998;139:4483-8.
54. Waxler SH, Brecher G. Obesity and food requirements in albino mice following administration of gold thioglucose. Am J Physiol. 1950;162:428-33.
55. Walker CG, Bryson JM, Phuyal JL, Caterson ID. Dietary modulation of cirulating leptin levels: site-specific changes in fat deposition and Ob mRNA expression. Horm Metab Res. 2002;34:176-81.
56. 22-5β = taurocholenic acid on hepatic cholesterol fatty acid in goldthioglucose obese mice fed low- or high-fat diets. J Nutr Biochem. 1999;10:638-43.
57. Roberts JL, Whittington FM, Enser M. Effects of litter size and subsequent gold-thioglucose-induced obesity on adipose tissue weight, distribution and cellularity in male and female mice: an age study. Brit J Nutr. 1988;59:519-33.
58. Waxler SH, Tabar P, Melcher LP. Obesity and the time of appearance of spontaneous mammary carcinoma in C3H mice. Cancer Res. 1953;13:276-8.
59. Waxler SH, Leef MF. Augmentation of mammary tumors in castrated obese C3H mice. Cancer Res. 1966;26:860-2.
60. Nkhata KJ, Ray A, Dogan S, Grande JP, Cleary MP. Mammary tumor development from T47D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements. Breast Cancer Res Treat. 2009;114:71-83.
61. Ray A, Nkhata KJ, Grande JP, Cleary MP. Diet-induced obesity and mammary tumor development in relation to estrogen receptor status. Cancer Letters. 2007;253:291-300.
62. Ray A, Nkhata K, Grande JP, Cleary MP. Diet-induced obesity and mammary tumor development in relation to estrogen receptor status. Cancer Lett. 2007;253:291-300.
63. Hong J, Holcomb VB, Kushiro K, Nunez NP. Estrogen inhibits the effects of obesity and alcohol on mammary tumors and fatty liver. Int J Oncol. 2011;39:1443-53.
64. Núnez NP, Perkins SN, Smith NCP, Berrigan D, Berendes DM, Varticovski L, et al. Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr Cancer. 2008;60:541.
65. De Angel RE, Conti CJ, Wheatley KE, Brenner AJ, Otto G, DeGraffenried LA, et al. The enhancing effects of obesity on mammary tumor growth and Akt/mTor pathway activation persist after weight loss and are reversed by RAD001. Mol Carcinog. 2013;52:446-58.
66. Gu J-W, Young E, Patterson SG, Makey KL, Wells J, Huang M, et al. Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice. Cancer Biol Ther. 2011;11:910-7.
67. Zheng Q, Dunlap SM, Zhu J, Downs-Kelly E, Rich J, Hursting SD, et al. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocrine-Related Cancer. 2011;18:491-503.
68. Brodie A, Lu Q, Nakamura J. Aromatase in the normal breast and breast cancer. J Steroid Biochem Molec Biol. 1997;61:281-6.
69. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987;45:277-82.
70. Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res. 2011;4:329-46.
71. Olson LK, Tan Y, Zhao Y, Aupperlee MD, Haslam SZ. Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness. Int J Obesity. 2010;34:1415-56.
72. Kamikawa A, Ichii O, Yamaji D, Imao T, Suzuki C, Okamatsu-Ogura Y, et al. Diet-induced obesity disrupts ductal development in the mammary glands of nonpregnanct mice. Dev Dynamics. 2009;238:1092-9.
73. Sonnenschein EG, Glickman LT, Goldschmidt LT, McKee LJ. Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. Am J Epidemiol. 1991;133:694-703.
74. Alenza DP, Rutterman GR, Peña L, Beynen AC, Cuesta P. Relation between habitual diet and canine mammary tumors in a case-control study. J Vet Intern Med. 1998;12:132-9.
75. Philibert JC, Snyder PW, Glickman N, Glickman LT, Knapp KW, Waters DJ. Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med. 2003;17:102-6.
76. Tan J, Buache E, Chenard M-P, Dali-Youcef N, Rio M-C. Adipocyte is a non-trivial, dynamic partner of breast cancer cells. Int J Dev Biol. 2011;55:851-9.
77. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocrine-Related Cancer. 2007;14:189-206.
78. Hefetz-Sela S, Scherer PE. Adipocytes: impact on tumor growth and potential sites for therapeutic intervention. Pharmac Ther. 2013;138:197-210.
79. Liu E, Samad F, Mueller BM. Local adipocytes enable estrogen-dependent breast cancer growth. Role of leptin and aromatase. Adipocyte. 2013;2:1-5.